Basic information
- Name:
Lithium carbonate
- CAS No.:
554-13-2
- Molecular Structure:
- Formula:
- Li2CO3
- Molecular Weight:
- 73.89 .
- Deleted CAS:
- 12767-19-0|216964-61-3
- Synonyms:
- Carbonicacid, lithium salt (1:2);Carbonicacid, dilithium salt (8CI,9CI);Lithium carbonate (6CI,7CI);Camcolit;Candamide;Carbolith;Carbolithium;Carbonic acid lithium salt(Li2CO3);Ceglution;Dilithium carbonate;Eskalith;Hypnorex;Limas;Liskonum;Lithane;Lithicarb;Lithium carbonate (Li2CO3);Lithobid;Lithocarb;Lithonate;Lithotabs;Micalith;NSC 16895;Phasal;Plenur;Priadel;
- EINECS:
- 209-062-5
- Density:
- 2.11 g/cm3
- Melting Point:
- 720 °C
- Boiling Point:
- 333.6 °C at 760 mmHg
- Flash Point:
- 169.8 °C
- Solubility:
- water: 13 g/L (20 °C)
- Appearance:
- white fine crystalline powder
- Hazard Symbols:
Xn,
C,
F- Risk Codes:
- 36/38-41-36/37/38-22-36-34-20/21/22-15-14-11
- Safety Description:
- 8-43-45-37/39-26-36/37-24/25-36/37/39-16-7/8-3/7/9 Details
- Transport Information:
- UN 3264 8/PG 3
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
Molecular Formula: Li2CO3
Molecular Weight: 73.89 g/mol
EINECS: 209-062-5
Melting point: 720 °C
Boiling point: 1342 °C(lit.)
Flash point: 1310 °C
Density: 2.11 g/mL at 25 °C
Water solubility: 13 g/L (20 °C)
Appearance: White fine crystalline powder
Structure of Lithium carbonate (CAS NO.554-13-2):
IUPAC Name: Dilithium carbonate
Product Category of Lithium carbonate (CAS NO.554-13-2): Inorganic Chemicals;Chemical Synthesis;Lithium Salts;Synthetic Reagents;Analytical Reagents for General Use;Digestion Reagents;Trace Analysis Reagents;Metal and Ceramic Science
Uses
Lithium carbonate (CAS NO.554-13-2), the most widely used of the compounds, is employed in the production of lithium metal and ft-its and enamels. Together with lithium fluoride (LiF), it serves as an additive for cryolite in the elec-trolytic pot line production of primary aluminum. It also is used to treat manic states and bipolar disorder, and is used in the manufacture of most LITHIUM-ion battery cathodes, which are made of lithlum cobalt oxide.
Production
Lithium carbonate (CAS NO.554-13-2) is manufactured from spodumene, which is by far the most important lithium-containing ore.
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | 500mg/kg (500mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 436, 1972. | |
| human | TDLo | oral | 4111mg/kg (4111mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: OTHER CHANGES | New England Journal of Medicine. Vol. 287, Pg. 867, 1972. |
| man | TDLo | oral | 8mg/kg (8mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | American Journal of Psychiatry. Vol. 141, Pg. 909, 1984. |
| man | TDLo | oral | 54mg/kg (54mg/kg) | BEHAVIORAL: SLEEP BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | New Zealand Medical Journal. Vol. 97, Pg. 23, 1984. |
| man | TDLo | oral | 1080mg/kg/13W (1080mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | Journal of Clinical Psychiatry. Vol. 47, Pg. 330, 1986. |
| man | TDLo | oral | 25gm/kg/4Y-I (25000mg/kg) | BEHAVIORAL: TREMOR SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE | Journal of Clinical Psychiatry. Vol. 46, Pg. 292, 1985. |
| mouse | LD50 | intraperitoneal | 236mg/kg (236mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: EXCITEMENT BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| mouse | LD50 | intravenous | 497mg/kg (497mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| mouse | LD50 | oral | 531mg/kg (531mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970. | |
| mouse | LD50 | subcutaneous | 413mg/kg (413mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970. | |
| rat | LD50 | intraperitoneal | 156mg/kg (156mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| rat | LD50 | intravenous | 241mg/kg (241mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| rat | LD50 | oral | 525mg/kg (525mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| rat | LD50 | subcutaneous | 434mg/kg (434mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
| women | TDLo | oral | 120mg/kg/10D- (120mg/kg) | BEHAVIORAL: EXCITEMENT | Journal of Clinical Psychiatry. Vol. 48, Pg. 81, 1987. |
| women | TDLo | oral | 612mg/kg/44D- (612mg/kg) | BEHAVIORAL: SLEEP SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | American Journal of Psychiatry. Vol. 152, Pg. 956, 1995. |
| women | TDLo | oral | 8760mg/kg/2Y- (8760mg/kg) | ENDOCRINE: THYROID WEIGHT (GOITER) ENDOCRINE: EVIDENCE OF THYROID HYPERFUNCTION | American Journal of Medicine. Vol. 99, Pg. 575, 1995. |
| women | TDLo | oral | 36500mg/kg/10 (36500mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED ENDOCRINE: DIABETES INSIPIDUS (NEPHROGENIC OR CNS) | Annales de Medecine Interne. Vol. 148, Pg. 284, 1997. |
| women | TDLo | unreported | 556mg/kg/32D (556mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS | JAMA, Journal of the American Medical Association. Vol. 213, Pg. 865, 1970. |
Safety Profile
Hazard Codes: 
Xn,
C,
F
Risk Statements: 36/38-41-36/37/38-22-36-34-20/21/22-15-14-11
36/38: Irritating to eyes and skin
36/37/38: Irritating to eyes, respiratory system and skin
41: Risk of serious damage to eyes
22: Harmful if swallowed
36: Irritating to the eyes
34: Causes burns
20/21/22: Harmful by inhalation, in contact with skin and if swallowed
15: Contact with water liberates extremely flammable gases
14: Reacts violently with water
11: Highly Flammable
Safety Statements: 8-43-45-37/39-26-36/37-24/25-36/37/39-16-7/8-3/7/9
8: Keep container dry
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
37/39: Wear suitable gloves and eye/face protection
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36/37: Wear suitable protective clothing and gloves
24/25: Avoid contact with skin and eyes
36/37/39: Wear suitable protective clothing, gloves and eye/face protection
16: Keep away from sources of ignition - No smoking
7/8: Keep container tightly closed and dry
Specification
Lithium carbonate , its cas register number is 554-13-2. It also can be called Lithonate ; Lithium hydroxide, solution ; Eskalith ; and Lithobid .